# Telmisartan With or Without Hydrochlorothiazide in Patients With Mild-to-moderate Hypertension

> **NCT02177435** · PHASE3 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 491 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Telmisartan
- **DRUG:** Telmisartan/Hydrochlorothiazide
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02177435
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-02
- **Primary completion:** 1999-09
- **Final completion:** —
- **Target enrollment:** 491 (ACTUAL)
- **Last updated:** 2014-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02177435

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02177435, "Telmisartan With or Without Hydrochlorothiazide in Patients With Mild-to-moderate Hypertension". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02177435. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*